4  Hemodialysis patients are estimated to lose ___ to ___ g of iron per year as a result of blood loss in the dialysis circuit and increased iron utilization secondary to ESA therapy
0  Do you feel findings from the Systolic Blood Pressure Intervention Trial (SPRINT) benefit all patients with CKD without question?
4  How concerned are you about patients in your practice being at risk of CV events due to masked hypertension?
3  What percentage of your patients experience hyperkalemia?
94  If tolvaptan for ADPKD was approved for use but not deemed to be cost-effective, would you still prescribe it to your patients?